Hongjian Yang

机构：Foshan University, Kunming Medical University, Suizhou Central Hospital, Zhejiang Cancer Hospital, Lifetech Scientific (China), Affiliated Hospital of Hebei University, Cancer Hospital of Chinese Academy of Medical Sciences, University of Chinese Academy of Sciences · ORCID：0000-0003-1583-2814

发表论文 106 篇 · 总被引 1230 次 · h-index 19

代表论文

• Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial (2024 · Nature Communications · 被引 32)
• Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer (2023 · Journal of Zhejiang University SCIENCE B · 被引 20)
• A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer (2024 · BMC Cancer · 被引 18)
• Advantages of contrast-enhanced ultrasound in the localization and diagnostics of sentinel lymph nodes in breast cancer (2023 · Journal of Zhejiang University SCIENCE B · 被引 10)
• Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary? (2024 · The Breast · 被引 8)
• Properties and hydration mechanism of foamed magnesium oxysulfate cement under acid modification (2024 · Case Studies in Construction Materials · 被引 4)